Overview of Global ATP Testing Market 2022 to 2027 including

Dublin, May 20, 2022 (GLOBE NEWSWIRE) — The “ATP testing market by product (consumables (kits, reagents, microplates), instrument (luminometer, spectrophotometers)), application (contamination, disease testing, drug discovery), user final (Hospitals, Pharmaceuticals, Food Testing) – The Global Forecast to 2027 report has been added to from ResearchAndMarkets.com offer.

ATP tests can measure cell viability based on the detection of ATP. Several detection methods can be used, such as colorimetry, fluorescence and bioluminescence.

This report provides information about the following pointers:

Market Penetration: Complete information on the product portfolios offered by the major players in the ATP testing market. The report analyzes this market by product, application and end user.

Product Improvement/Innovation: Detailed information on upcoming trends and product launches in the global ATP testing market

Market Development: Comprehensive insights into lucrative emerging markets by product, application and end user

Market Diversification: Extensive information about new products or product enhancements, growing geographies, recent developments, and investments in the global ATP Testing market

Competitive Assessment: In-depth assessment of market shares, growth strategies, product offerings, competitive leadership mapping, and capabilities of key players in the global ATP Testing market.

Market overview

The Global ATP Testing Market is expected to reach USD 412.4 Million by 2027, from USD 276.0 Million in 2022, growing at a CAGR of 8.4%.

The growth of this market can be largely attributed to growing concerns over food safety, increasing demand for ATP testing from pharmaceutical and biotechnology companies, increasing investment in pharmaceutical and biotechnology R&D, growing prevalence of cancer and other chronic and infectious diseases, and moving from culture-based tests to rapid tests.

However, the high cost of instruments and the inability to differentiate between extracellular and intracellular ATP is expected to limit the growth of this market to some extent.

The consumables and accessories segment accounted for the largest share of ATP assays, based on revenue in 2021

On the basis of product, the ATP testing market is segmented into consumables and accessories, and instruments. The large share of the consumables and accessories segment is attributed to the extensive use of ATP assays in research institutes to measure cell viability, increase in drug discovery due to an increase in chronic diseases that require tumor tests and cell proliferation (in cancer), and the repeated purchase of consumables by pharmaceutical and biotechnology companies.

Contamination testing accounted for the largest share of the market

The ATP testing market is segmented into contamination testing, disease testing, and drug discovery and development. The large share of the contamination testing segment can be attributed to increasing regulatory stringency of pharmaceutical and food and beverage companies for uncontaminated production, an increase in drug discovery post COVID-19, and the need for cleaning and disinfection of environmental surfaces. in the hospital.

Pharmaceutical and biotechnology companies hold the largest market share, by end user

The large share of pharmaceutical and biotechnology companies in the end-user segment can be attributed to the presence of a large number of pharmaceutical players with increasing investments in this market, increasing regulatory approvals for cell culture-based vaccines which require the use of ATP assays in contamination testing, business expansion of various pharmaceutical companies, increasing demand for cell and gene therapies for chronic diseases, significant R&D in pharmaceutical and biopharmaceutical companies, increasing production of COVID-19 drugs, the growing adoption of cell-based assays for drug development, and the ease of use of ATP assays in contamination testing.

APAC will experience the highest growth during the forecast period

The Asia-Pacific region is expected to grow at the highest CAGR during the forecast period 2022-2027. This regional market is expected to witness the highest growth rate over the forecast period as several APAC countries are witnessing an increasing number of proteomics, genomics and stem cell research activities.

Growing incidence of chronic and infectious diseases, increase in drug discovery and development studies, favorable regulatory guidelines, increasing focus of global market players on emerging Asian economies, increase in funding for research, increased investments by pharmaceutical and biotechnology companies and the modernization of research infrastructures are some of them. key factors driving the ATP assays market.

The breakdown of the main participants was as mentioned below:

  • By business type – Level 1-35%, Level 2-45% and Level 3-20%
  • By Designation – C Level-35%, Director Level-25%, Others-40%
  • By region – North America-45%, Europe-30%, Asia-Pacific-20%, Latin America-3%, Middle East and Africa-2%

Research coverage

The report analyzes the ATP Testing market and aims to estimate the market size and future growth potential of this market based on various segments such as product, application, end-user and region. The report also includes a product portfolio matrix of various ATP assay products available in the market. The report also provides a competitive analysis of key players in this market along with their company profiles, product offerings, and key market strategies.

Reasons to buy the report

The report will enrich the established businesses as well as the new entrants/small businesses to take the pulse of the market, which would help them to gain a larger share of the market. Companies buying the report could use one or more of the strategies mentioned below to strengthen their position in the market.

Key Players of ATP Testing Market are:


AAT BioqueT

Abcam plc

Abnova Company

Agilent Technologies, Inc.

Bio Shield Tech LLC

BioThema AB


Canvax Biotech SL

chemical caiman

Cell signaling technology

Charm Sciences, Inc.


Creative bioarray

Danaher Corporation

Elabscience Biotechnology Inc.

Geno Technology, Inc.

Lonza Group

MBL International Company

Merck KGaA

NEOGEN Corporation

PerkinElmer, Inc.

Promega Corporation

PromoCell GmbH

Ruhof Company

ThermoFisher Scientific, Inc.

For more information about this report visit https://www.researchandmarkets.com/r/ma6ha


Comments are closed.